Effect of d-tubocurarine pretreatment on succinylcholine twitch augmentation and neuromuscular blockade
- PMID: 2363529
- DOI: 10.1213/00000539-199007000-00009
Effect of d-tubocurarine pretreatment on succinylcholine twitch augmentation and neuromuscular blockade
Abstract
Subparalyzing doses of d-tubocurarine (dTC) given before succinylcholine decrease the duration of neuromuscular blockade. In animal preparations, they also abolish succinylcholine-induced twitch augmentation, defined as a greater-than-maximal contraction in response to a single stimulus. To determine quantitatively the effect of dTC on succinylcholine potency and on twitch augmentation in humans, 60 adult patients, ASA physical status I or II, were assigned randomly to receive either 0.05 mg/kg of dTC or saline 2 min before induction of anesthesia with fentanyl and thiopental. Train-of-four stimulation was applied every 12 s to the ulnar nerve and the force of contraction of the adductor pollicis muscle was measured. One minute after induction of anesthesia, 0.15, 0.20, 0.25, 0.35, or 0.50 mg/kg of succinylcholine was given. The height of the first twitch (T1) reached 121% +/- 6% (mean +/- SEM) of control without dTC, and was virtually abolished by dTC pretreatment (105% +/- 1%, P less than 0.01). Twitch augmentation was more noticeable with lower doses of succinylcholine, and was not observed in the response to the fourth stimulus of the train of four (T4). The potency of succinylcholine was decreased by approximately one-half in the dTC-pretreated groups. The ED50 was 0.27 +/- 0.04 mg/kg without dTC and 0.50 +/- 0.06 mg/kg with dTC (P less than 0.002). The corresponding values for ED90 were 0.51 +/- 0.07 and 1.02 +/- 0.12 mg/kg, respectively (P less than 0.02). The ED95 values were 0.63 +/- 0.09 and 1.28 +/- 0.15 mg/kg, respectively (P less than 0.02). The slopes of the regression lines did not deviate significantly from parallelism.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Neuromuscular effects of succinylcholine following different pretreatments.J Clin Anesth. 1993 Jan-Feb;5(1):50-3. doi: 10.1016/0952-8180(93)90088-v. J Clin Anesth. 1993. PMID: 8442969 Clinical Trial.
-
Neuromuscular effects of enflurane, alone and combined with d-Tubocurarine, pancuronium, and succinylcholine, in man.Anesthesiology. 1975 Feb;42(2):173-8. doi: 10.1097/00000542-197502000-00010. Anesthesiology. 1975. PMID: 1115366
-
Nitrous oxide potentiates succinylcholine neuromuscular blockade in humans.Anesth Analg. 1991 Jan;72(1):18-21. doi: 10.1213/00000539-199101000-00004. Anesth Analg. 1991. PMID: 1845791
-
Dose-related effects of succinylcholine on the adductor pollicis and masseter muscles in children.Can J Anaesth. 1990 Jan;37(1):15-20. doi: 10.1007/BF03007477. Can J Anaesth. 1990. PMID: 2403850 Clinical Trial.
-
The effect of a subthreshold dose of d-tubocurarine on the neuromuscular blocking action of succinylcholine in anesthetized man.Acta Anaesthesiol Scand. 1974;18(2):71-8. doi: 10.1111/j.1399-6576.1974.tb00845.x. Acta Anaesthesiol Scand. 1974. PMID: 4428934 No abstract available.
Cited by
-
An automated platform for simultaneous, longitudinal analysis of engineered neuromuscular tissues for applications in neurotoxin potency testing.Curr Res Toxicol. 2025 Jan 26;8:100218. doi: 10.1016/j.crtox.2025.100218. eCollection 2025. Curr Res Toxicol. 2025. PMID: 39944108 Free PMC article.
-
Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function.Anesthesiology. 2007 Oct;107(4):621-9. doi: 10.1097/01.anes.0000281928.88997.95. Anesthesiology. 2007. PMID: 17893459 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources